Description
LL-37 is a 37-amino-acid peptide derived from a human protein called cathelicidin. It has broad-spectrum antimicrobial activity, disrupting bacterial membranes, and it can break down biofilms. Beyond fighting infections, it also modulates the immune response, acting both as a pro-inflammatory and anti-inflammatory agent. It promotes tissue repair, angiogenesis, and cell migration, but it’s also linked to conditions like psoriasis and even neurodegeneration, so its effects are complex and still being studied.
LL-37 / Human Cathelicidin Antimicrobial Peptide Research Details
LL-37 is the only human cathelicidin antimicrobial peptide and is heavily studied in innate-immunity literature. Research examines bacterial membrane disruption, biofilm biology, host-cell signaling, wound environments, inflammation, and context-dependent immune effects.
99%+ target purity or lot-specific COA value
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
Lyophilized research material unless otherwise specified by COA
Research use only
Research Background
Cationic amphipathic antimicrobial peptide derived from human cathelicidin hCAP18; studied for membrane interaction, biofilm, chemotaxis, and immune modulation. Key OneBio research contexts include innate-immunity assays, antimicrobial peptide models, biofilm research, epithelial signaling, and wound-environment studies.
Specifications
| Compound | LL-37 / Human Cathelicidin Antimicrobial Peptide |
| SKU / Product | ll37 |
| Molecular Weight | ~4493.3 g/mol |
| Formula / Classification | C205H341N61O52 |
| Database / Identity Note | PubChem CID 16133648 |
| Storage | -4°F long-term; 35-46°F short-term refrigerated; 39°F after reconstitution for up to 30 days when appropriate for the research protocol |
Quality Verification
Each batch should be reviewed against its Certificate of Analysis, including identity confirmation, purity method, mass/sequence or component confirmation, appearance, and lot-specific handling notes. Blend products should be checked against component-ratio documentation where available.
Laboratory Preparation
Prepare only inside a qualified laboratory using validated solvent choice, concentration, sterility, and storage protocols. For lyophilized peptides, use sterile deionized water or bacteriostatic water when appropriate for the research protocol, mix gently, maintain cold-chain handling, and avoid repeated freeze-thaw cycles.
Product-Specific Q&A
What is LL-37 / Human Cathelicidin Antimicrobial Peptide used for in research?
LL-37 / Human Cathelicidin Antimicrobial Peptide is used as a research material for innate-immunity assays, antimicrobial peptide models, biofilm research, epithelial signaling, and wound-environment studies. It is not offered for diagnostic, therapeutic, clinical, veterinary, or human-use applications.
What mechanism is most relevant for LL-37 / Human Cathelicidin Antimicrobial Peptide?
Cationic amphipathic antimicrobial peptide derived from human cathelicidin hCAP18; studied for membrane interaction, biofilm, chemotaxis, and immune modulation.
How should LL-37 / Human Cathelicidin Antimicrobial Peptide identity and purity be verified?
Use the lot-specific Certificate of Analysis to confirm identity, purity, mass/sequence or component profile, and any method-specific data such as LC-MS/HPLC. Technical values on this page are research references and should be checked against the delivered lot.
What storage conditions apply to LL-37 / Human Cathelicidin Antimicrobial Peptide?
-4°F long-term; 35-46°F short-term refrigerated; 39°F after reconstitution for up to 30 days when appropriate for the research protocol. Keep sealed, dry, protected from light, and avoid repeated freeze-thaw cycles after preparation.
References
- PMID 39351216: Signaling pathways and targeted therapy for rosacea. Frontiers in immunology 2024.
- PMID 40063262: Human antimicrobial/host defense peptide LL-37 may prevent the spread of a local infection through multiple mechanisms: an update. Inflammation research : official journal of the European Histamine Research Society … [et al.] 2025.
- PMID 30980360: Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37. Advances in experimental medicine and biology 2019.

Reviews
There are no reviews yet.